News from Advicenne A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 06, 2017, 02:30 ET Advicenne Announces Positive 6-Month Extension Study Data from Pivotal Phase III Study of ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA)

- Data presented at the American Society of Nephrology (ASN) meeting in New Orleans - Positive data will form basis for application seeking...


Sep 11, 2017, 01:00 ET Advicenne Announces Positive Pivotal Phase III Clinical Data for ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA)

ADV7103 could potentially be the first approved treatment for dRTA Advicenne, a late-stage biopharmaceutical company focused on the development...


Jul 05, 2017, 03:00 ET Advicenne Receives Orphan Drug Designation From the EU for ADV7103 for the Treatment of Distal Renal Tubular Acidosis

Advicenne, a late-stage biopharmaceutical company focused on the development of paediatric-friendly therapeutics for the treatment of orphan renal...


Jun 21, 2017, 09:30 ET Advicenne to Present Preliminary Phase III Clinical Data on ADV7103 at the Upcoming European Society of Paediatric Nephrology's Annual Meeting

Advicenne, a late-stage biopharmaceutical company focused on the development of paediatric-friendly therapeutics for the treatment of orphan renal...


Mar 20, 2017, 04:00 ET Advicenne Announces the Closing of a €16 Million Financing Round

Advicenne, a late-stage biopharmaceutical company focused on the development of paediatric friendly therapeutics for the treatment of orphan renal...